Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Review Articles

Expert opinion on the optimal use of sevelamer in clinical practice in Southeast Asia: Bancha Satirapoj, Chong Men Leong, Christopher Thiam Seong Lim et al.; Received July 24, 2025 Accepted November 28, 2025 Published online April 14, 2026; [Epub ahead of print]; Full text PubReader ePub PDF

Original Articles

Tegoprazan and the risk of end-stage kidney disease progression: a nationwide Korean study: Yu Jeong Lee, Jinmi Kim, Dong Han Yu, Nam Kyung Je, Harin Rhee; Received October 31, 2025 Accepted January 2, 2026 Published online April 2, 2026; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Longitudinal triglyceride-glucose index trajectories and kidney outcomes in patients with metabolic dysfunctionassociated fatty liver disease: Jong Hyun Jhee, Wooram Bae, Hyo Jeong Kim et al.; Received July 24, 2025 Accepted December 8, 2025 Published online March 6, 2026; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Review Article s

Artificial intelligence virtual cells as a new paradigm in nephrology: from multiomics integration to clinical translation: Yongzheng Hu, Yabin Wang, Xinyue Qi, Wei Jiang; Received September 6, 2025 Accepted November 28, 2025 Published online February 13, 2026; [Epub ahead of print]; Full text PubReader ePub PDF

Original Articles

Ferric citrate for iron deficiency anemia in non-dialysis dependent chronic kidney disease: a randomized phase III study: Mei-Yi Wu, Chin-Chan Lee, Chien-Te Lee et al.; Received May 19, 2025 Accepted November 24, 2025 Published online January 21, 2026; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Geographic disparities in kidney function decline: a matched cohort analysis of urban and rural populations in Korea: Ji Eun Kim, Eun Jung Cho, Shin Young Ahn, Gang-Jee Ko, Young Joo Kwon; Received June 4, 2024 Accepted August 22, 2025 Published online December 24, 2025; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Outpatient visit intervals in chronic kidney disease: adherence to Kidney Disease: Improving Global Outcomes recommendations and determinants of variation: Somi Kim, Ga Young Heo, Cheol Ho Park et al.; Received July 6, 2025 Accepted November 17, 2025 Published online December 16, 2025; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Tau, a microtubule-associated protein, is upregulated and promotes kidney damage in chronic kidney disease: Seong Woo Lee, Seung Seob Son, Hee Seul Jeong et al.; Received April 28, 2025 Accepted September 20, 2025 Published online December 12, 2025; [Epub ahead of print]; Full text PubReader PDF Supplementary Material

Frailty-related factors and 1-year renal function change after sodium-glucose cotransporter-2 inhibitors in elderly chronic kidney disease patients: Hye-Mi Noh, Sei Hong Min, Hyung-Seok Lee, Sung Gyun Kim, Jun Goo Kang, Jwa-Kyung Kim; Received April 16, 2025 Accepted September 1, 2025 Published online December 8, 2025; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Protein-energy wasting in chronic kidney disease patients not receiving kidney replacement therapy: risk factors for all-cause death and composite outcomes: findings from KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD): Hojung Lee, Hyanglim Lee, Hyunjin Ryu et al.; Received April 15, 2025 Accepted July 9, 2025 Published online November 28, 2025; [Epub ahead of print]; Full text PubReader ePub PDF

The impact of adolescent smoking initiation on the risk of end-stage kidney disease: a nationwide cohort study: Seong Geun Kim, Jeong Min Cho, Soojin Lee et al.; Received November 28, 2024 Accepted May 30, 2025 Published online September 9, 2025; [Epub ahead of print]
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Volume 45, No. 3

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.8

MOST VIEWED MOST CITED

54,307	Factors associated with gait speed: results from the RolE of AST120 (Renamezin) in sarCOpenia preVEntion in pRe-dialYsis chronic kidney disease patients (RECOVERY) study
31,109	The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions
13,595	Management of high-flow arteriovenous access
11,815	Precision medicine for focal segmental glomerulosclerosis
7,829	Safety and efficacy of glucagon-like peptide 1 receptor agonists in solid organ transplant recipients with diabetes mellitus: a systematic review and meta-analysis

Cited By 17	Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future
Cited By 17	The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions
Cited By 15	Pathogenesis and management of renal fibrosis induced by unilateral ureteral obstruction
Cited By 15	Sarcopenia, sarcopenic obesity, and frailty in individuals with chronic kidney disease: a comprehensive review
Cited By 14	Artificial intelligence and machine learning’s role in sepsis-associated acute kidney injury

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2026 by The Korean Society of Nephrology.